22 Biopharma Stocks With Breakout Potential in 2012

Description:

According to Adam Feuerstein, "Drug approval decisions garner big headlines, but savvy and successful biotech investors know that making smart trading decisions ahead of important clinical trial results is the ticket to banking serious coin." Read more here.

>>Also: 6 Stocks to Play if the Market Tanks

>>Also: 3 Hot Stocks for a Sideways Market

Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

5 Stocks Insiders Love Right Now

07.30.14 | 11:35 AM

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. They might need the cash for a big pe...

Dividend Preview: 5 Stocks Ready to Pay You More

07.30.14 | 10:47 AM

BALTIMORE (Stockpickr) -- The S&P 500 may be pushing up against new all-time highs this month, but whatever you do, don't forget about dividends. ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter